Vigabatrin(CAS?60643-86-9) is a gamma-amino acid having a gamma-vinyl GABA structure.
The global market for Vigabatrin API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Vigabatrin API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Vigabatrin API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Vigabatrin API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Vigabatrin API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Vigabatrin API players cover Hetero Drugs, Aurobindo Pharma Limited, Intas Pharmaceuticals, Metrochem API Private Limited and SMS Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Vigabatrin API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Vigabatrin API market, with both quantitative and qualitative data, to help readers understand how the Vigabatrin API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.
Market Segmentation:
The study segments the Vigabatrin API market and forecasts the market size by Purity (Above 98 % and Above 99 %,), by Application (Tablets, Oral Solution and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
Above 98 %
Above 99 %
Segmentation by application
Tablets
Oral Solution
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Hetero Drugs
Aurobindo Pharma Limited
Intas Pharmaceuticals
Metrochem API Private Limited
SMS Pharmaceuticals
Biophore India Pharmaceuticals Pvt Ltd
Divis Laboratories Ltd.
Granules India Limited
Guangzhou Tosun Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Vigabatrin API, Research Methodology, etc.
Chapter 2: Executive Summary, global Vigabatrin API market size (sales and revenue) and CAGR, Vigabatrin API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Vigabatrin API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Vigabatrin API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Vigabatrin API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Hetero Drugs, Aurobindo Pharma Limited, Intas Pharmaceuticals, Metrochem API Private Limited, SMS Pharmaceuticals, Biophore India Pharmaceuticals Pvt Ltd, Divis Laboratories Ltd., Granules India Limited and Guangzhou Tosun Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vigabatrin API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vigabatrin API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vigabatrin API by Country/Region, 2017, 2022 & 2028
2.2 Vigabatrin API Segment by Purity
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Vigabatrin API Sales by Purity
2.3.1 Global Vigabatrin API Sales Market Share by Purity (2017-2022)
2.3.2 Global Vigabatrin API Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Vigabatrin API Sale Price by Purity (2017-2022)
2.4 Vigabatrin API Segment by Application
2.4.1 Tablets
2.4.2 Oral Solution
2.4.3 Others
2.5 Vigabatrin API Sales by Application
2.5.1 Global Vigabatrin API Sale Market Share by Application (2017-2022)
2.5.2 Global Vigabatrin API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vigabatrin API Sale Price by Application (2017-2022)
3 Global Vigabatrin API by Company
3.1 Global Vigabatrin API Breakdown Data by Company
3.1.1 Global Vigabatrin API Annual Sales by Company (2020-2022)
3.1.2 Global Vigabatrin API Sales Market Share by Company (2020-2022)
3.2 Global Vigabatrin API Annual Revenue by Company (2020-2022)
3.2.1 Global Vigabatrin API Revenue by Company (2020-2022)
3.2.2 Global Vigabatrin API Revenue Market Share by Company (2020-2022)
3.3 Global Vigabatrin API Sale Price by Company
3.4 Key Manufacturers Vigabatrin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vigabatrin API Product Location Distribution
3.4.2 Players Vigabatrin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vigabatrin API by Geographic Region
4.1 World Historic Vigabatrin API Market Size by Geographic Region (2017-2022)
4.1.1 Global Vigabatrin API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vigabatrin API Annual Revenue by Geographic Region
4.2 World Historic Vigabatrin API Market Size by Country/Region (2017-2022)
4.2.1 Global Vigabatrin API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vigabatrin API Annual Revenue by Country/Region
4.3 Americas Vigabatrin API Sales Growth
4.4 APAC Vigabatrin API Sales Growth
4.5 Europe Vigabatrin API Sales Growth
4.6 Middle East & Africa Vigabatrin API Sales Growth
5 Americas
5.1 Americas Vigabatrin API Sales by Country
5.1.1 Americas Vigabatrin API Sales by Country (2017-2022)
5.1.2 Americas Vigabatrin API Revenue by Country (2017-2022)
5.2 Americas Vigabatrin API Sales by Purity
5.3 Americas Vigabatrin API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vigabatrin API Sales by Region
6.1.1 APAC Vigabatrin API Sales by Region (2017-2022)
6.1.2 APAC Vigabatrin API Revenue by Region (2017-2022)
6.2 APAC Vigabatrin API Sales by Purity
6.3 APAC Vigabatrin API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vigabatrin API by Country
7.1.1 Europe Vigabatrin API Sales by Country (2017-2022)
7.1.2 Europe Vigabatrin API Revenue by Country (2017-2022)
7.2 Europe Vigabatrin API Sales by Purity
7.3 Europe Vigabatrin API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vigabatrin API by Country
8.1.1 Middle East & Africa Vigabatrin API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vigabatrin API Revenue by Country (2017-2022)
8.2 Middle East & Africa Vigabatrin API Sales by Purity
8.3 Middle East & Africa Vigabatrin API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vigabatrin API
10.3 Manufacturing Process Analysis of Vigabatrin API
10.4 Industry Chain Structure of Vigabatrin API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vigabatrin API Distributors
11.3 Vigabatrin API Customer
12 World Forecast Review for Vigabatrin API by Geographic Region
12.1 Global Vigabatrin API Market Size Forecast by Region
12.1.1 Global Vigabatrin API Forecast by Region (2023-2028)
12.1.2 Global Vigabatrin API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vigabatrin API Forecast by Purity
12.7 Global Vigabatrin API Forecast by Application
13 Key Players Analysis
13.1 Hetero Drugs
13.1.1 Hetero Drugs Company Information
13.1.2 Hetero Drugs Vigabatrin API Product Offered
13.1.3 Hetero Drugs Vigabatrin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hetero Drugs Main Business Overview
13.1.5 Hetero Drugs Latest Developments
13.2 Aurobindo Pharma Limited
13.2.1 Aurobindo Pharma Limited Company Information
13.2.2 Aurobindo Pharma Limited Vigabatrin API Product Offered
13.2.3 Aurobindo Pharma Limited Vigabatrin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Aurobindo Pharma Limited Main Business Overview
13.2.5 Aurobindo Pharma Limited Latest Developments
13.3 Intas Pharmaceuticals
13.3.1 Intas Pharmaceuticals Company Information
13.3.2 Intas Pharmaceuticals Vigabatrin API Product Offered
13.3.3 Intas Pharmaceuticals Vigabatrin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Intas Pharmaceuticals Main Business Overview
13.3.5 Intas Pharmaceuticals Latest Developments
13.4 Metrochem API Private Limited
13.4.1 Metrochem API Private Limited Company Information
13.4.2 Metrochem API Private Limited Vigabatrin API Product Offered
13.4.3 Metrochem API Private Limited Vigabatrin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Metrochem API Private Limited Main Business Overview
13.4.5 Metrochem API Private Limited Latest Developments
13.5 SMS Pharmaceuticals
13.5.1 SMS Pharmaceuticals Company Information
13.5.2 SMS Pharmaceuticals Vigabatrin API Product Offered
13.5.3 SMS Pharmaceuticals Vigabatrin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 SMS Pharmaceuticals Main Business Overview
13.5.5 SMS Pharmaceuticals Latest Developments
13.6 Biophore India Pharmaceuticals Pvt Ltd
13.6.1 Biophore India Pharmaceuticals Pvt Ltd Company Information
13.6.2 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Product Offered
13.6.3 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Biophore India Pharmaceuticals Pvt Ltd Main Business Overview
13.6.5 Biophore India Pharmaceuticals Pvt Ltd Latest Developments
13.7 Divis Laboratories Ltd.
13.7.1 Divis Laboratories Ltd. Company Information
13.7.2 Divis Laboratories Ltd. Vigabatrin API Product Offered
13.7.3 Divis Laboratories Ltd. Vigabatrin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Divis Laboratories Ltd. Main Business Overview
13.7.5 Divis Laboratories Ltd. Latest Developments
13.8 Granules India Limited
13.8.1 Granules India Limited Company Information
13.8.2 Granules India Limited Vigabatrin API Product Offered
13.8.3 Granules India Limited Vigabatrin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Granules India Limited Main Business Overview
13.8.5 Granules India Limited Latest Developments
13.9 Guangzhou Tosun Pharmaceutical
13.9.1 Guangzhou Tosun Pharmaceutical Company Information
13.9.2 Guangzhou Tosun Pharmaceutical Vigabatrin API Product Offered
13.9.3 Guangzhou Tosun Pharmaceutical Vigabatrin API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Guangzhou Tosun Pharmaceutical Main Business Overview
13.9.5 Guangzhou Tosun Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Vigabatrin API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vigabatrin API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Vigabatrin API Sales by Purity (2017-2022) & (Kg)
Table 6. Global Vigabatrin API Sales Market Share by Purity (2017-2022)
Table 7. Global Vigabatrin API Revenue by Purity (2017-2022) & ($ million)
Table 8. Global Vigabatrin API Revenue Market Share by Purity (2017-2022)
Table 9. Global Vigabatrin API Sale Price by Purity (2017-2022) & (US$/Kg)
Table 10. Global Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 11. Global Vigabatrin API Sales Market Share by Application (2017-2022)
Table 12. Global Vigabatrin API Revenue by Application (2017-2022)
Table 13. Global Vigabatrin API Revenue Market Share by Application (2017-2022)
Table 14. Global Vigabatrin API Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Vigabatrin API Sales by Company (2020-2022) & (Kg)
Table 16. Global Vigabatrin API Sales Market Share by Company (2020-2022)
Table 17. Global Vigabatrin API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Vigabatrin API Revenue Market Share by Company (2020-2022)
Table 19. Global Vigabatrin API Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Vigabatrin API Producing Area Distribution and Sales Area
Table 21. Players Vigabatrin API Products Offered
Table 22. Vigabatrin API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vigabatrin API Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Vigabatrin API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Vigabatrin API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Vigabatrin API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Vigabatrin API Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Vigabatrin API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Vigabatrin API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Vigabatrin API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Vigabatrin API Sales by Country (2017-2022) & (Kg)
Table 34. Americas Vigabatrin API Sales Market Share by Country (2017-2022)
Table 35. Americas Vigabatrin API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Vigabatrin API Revenue Market Share by Country (2017-2022)
Table 37. Americas Vigabatrin API Sales by Type (2017-2022) & (Kg)
Table 38. Americas Vigabatrin API Sales Market Share by Purity (2017-2022)
Table 39. Americas Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 40. Americas Vigabatrin API Sales Market Share by Application (2017-2022)
Table 41. APAC Vigabatrin API Sales by Region (2017-2022) & (Kg)
Table 42. APAC Vigabatrin API Sales Market Share by Region (2017-2022)
Table 43. APAC Vigabatrin API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Vigabatrin API Revenue Market Share by Region (2017-2022)
Table 45. APAC Vigabatrin API Sales by Purity (2017-2022) & (Kg)
Table 46. APAC Vigabatrin API Sales Market Share by Purity (2017-2022)
Table 47. APAC Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 48. APAC Vigabatrin API Sales Market Share by Application (2017-2022)
Table 49. Europe Vigabatrin API Sales by Country (2017-2022) & (Kg)
Table 50. Europe Vigabatrin API Sales Market Share by Country (2017-2022)
Table 51. Europe Vigabatrin API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Vigabatrin API Revenue Market Share by Country (2017-2022)
Table 53. Europe Vigabatrin API Sales by Type (2017-2022) & (Kg)
Table 54. Europe Vigabatrin API Sales Market Share by Purity (2017-2022)
Table 55. Europe Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 56. Europe Vigabatrin API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Vigabatrin API Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Vigabatrin API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Vigabatrin API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Vigabatrin API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vigabatrin API Sales by Purity (2017-2022) & (Kg)
Table 62. Middle East & Africa Vigabatrin API Sales Market Share by Purity (2017-2022)
Table 63. Middle East & Africa Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Vigabatrin API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Vigabatrin API
Table 66. Key Market Challenges & Risks of Vigabatrin API
Table 67. Key Industry Trends of Vigabatrin API
Table 68. Vigabatrin API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Vigabatrin API Distributors List
Table 71. Vigabatrin API Customer List
Table 72. Global Vigabatrin API Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Vigabatrin API Sales Market Forecast by Region
Table 74. Global Vigabatrin API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Vigabatrin API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Vigabatrin API Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Vigabatrin API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Vigabatrin API Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Vigabatrin API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Vigabatrin API Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Vigabatrin API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Vigabatrin API Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Vigabatrin API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Vigabatrin API Sales Forecast by Purity (2023-2028) & (Kg)
Table 85. Global Vigabatrin API Sales Market Share Forecast by Purity (2023-2028)
Table 86. Global Vigabatrin API Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 87. Global Vigabatrin API Revenue Market Share Forecast by Purity (2023-2028)
Table 88. Global Vigabatrin API Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Vigabatrin API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Vigabatrin API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Vigabatrin API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Hetero Drugs Basic Information, Vigabatrin API Manufacturing Base, Sales Area and Its Competitors
Table 93. Hetero Drugs Vigabatrin API Product Offered
Table 94. Hetero Drugs Vigabatrin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. Hetero Drugs Main Business
Table 96. Hetero Drugs Latest Developments
Table 97. Aurobindo Pharma Limited Basic Information, Vigabatrin API Manufacturing Base, Sales Area and Its Competitors
Table 98. Aurobindo Pharma Limited Vigabatrin API Product Offered
Table 99. Aurobindo Pharma Limited Vigabatrin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. Aurobindo Pharma Limited Main Business
Table 101. Aurobindo Pharma Limited Latest Developments
Table 102. Intas Pharmaceuticals Basic Information, Vigabatrin API Manufacturing Base, Sales Area and Its Competitors
Table 103. Intas Pharmaceuticals Vigabatrin API Product Offered
Table 104. Intas Pharmaceuticals Vigabatrin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. Intas Pharmaceuticals Main Business
Table 106. Intas Pharmaceuticals Latest Developments
Table 107. Metrochem API Private Limited Basic Information, Vigabatrin API Manufacturing Base, Sales Area and Its Competitors
Table 108. Metrochem API Private Limited Vigabatrin API Product Offered
Table 109. Metrochem API Private Limited Vigabatrin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. Metrochem API Private Limited Main Business
Table 111. Metrochem API Private Limited Latest Developments
Table 112. SMS Pharmaceuticals Basic Information, Vigabatrin API Manufacturing Base, Sales Area and Its Competitors
Table 113. SMS Pharmaceuticals Vigabatrin API Product Offered
Table 114. SMS Pharmaceuticals Vigabatrin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. SMS Pharmaceuticals Main Business
Table 116. SMS Pharmaceuticals Latest Developments
Table 117. Biophore India Pharmaceuticals Pvt Ltd Basic Information, Vigabatrin API Manufacturing Base, Sales Area and Its Competitors
Table 118. Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Product Offered
Table 119. Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. Biophore India Pharmaceuticals Pvt Ltd Main Business
Table 121. Biophore India Pharmaceuticals Pvt Ltd Latest Developments
Table 122. Divis Laboratories Ltd. Basic Information, Vigabatrin API Manufacturing Base, Sales Area and Its Competitors
Table 123. Divis Laboratories Ltd. Vigabatrin API Product Offered
Table 124. Divis Laboratories Ltd. Vigabatrin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Divis Laboratories Ltd. Main Business
Table 126. Divis Laboratories Ltd. Latest Developments
Table 127. Granules India Limited Basic Information, Vigabatrin API Manufacturing Base, Sales Area and Its Competitors
Table 128. Granules India Limited Vigabatrin API Product Offered
Table 129. Granules India Limited Vigabatrin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Granules India Limited Main Business
Table 131. Granules India Limited Latest Developments
Table 132. Guangzhou Tosun Pharmaceutical Basic Information, Vigabatrin API Manufacturing Base, Sales Area and Its Competitors
Table 133. Guangzhou Tosun Pharmaceutical Vigabatrin API Product Offered
Table 134. Guangzhou Tosun Pharmaceutical Vigabatrin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Guangzhou Tosun Pharmaceutical Main Business
Table 136. Guangzhou Tosun Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Vigabatrin API
Figure 2. Vigabatrin API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vigabatrin API Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Vigabatrin API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vigabatrin API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Vigabatrin API Sales Market Share by Purity in 2021
Figure 12. Global Vigabatrin API Revenue Market Share by Purity (2017-2022)
Figure 13. Vigabatrin API Consumed in Tablets
Figure 14. Global Vigabatrin API Market: Tablets (2017-2022) & (Kg)
Figure 15. Vigabatrin API Consumed in Oral Solution
Figure 16. Global Vigabatrin API Market: Oral Solution (2017-2022) & (Kg)
Figure 17. Vigabatrin API Consumed in Others
Figure 18. Global Vigabatrin API Market: Others (2017-2022) & (Kg)
Figure 19. Global Vigabatrin API Sales Market Share by Application (2017-2022)
Figure 20. Global Vigabatrin API Revenue Market Share by Application in 2021
Figure 21. Vigabatrin API Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Vigabatrin API Revenue Market Share by Company in 2021
Figure 23. Global Vigabatrin API Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Vigabatrin API Revenue Market Share by Geographic Region in 2021
Figure 25. Global Vigabatrin API Sales Market Share by Region (2017-2022)
Figure 26. Global Vigabatrin API Revenue Market Share by Country/Region in 2021
Figure 27. Americas Vigabatrin API Sales 2017-2022 (Kg)
Figure 28. Americas Vigabatrin API Revenue 2017-2022 ($ Millions)
Figure 29. APAC Vigabatrin API Sales 2017-2022 (Kg)
Figure 30. APAC Vigabatrin API Revenue 2017-2022 ($ Millions)
Figure 31. Europe Vigabatrin API Sales 2017-2022 (Kg)
Figure 32. Europe Vigabatrin API Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Vigabatrin API Sales 2017-2022 (Kg)
Figure 34. Middle East & Africa Vigabatrin API Revenue 2017-2022 ($ Millions)
Figure 35. Americas Vigabatrin API Sales Market Share by Country in 2021
Figure 36. Americas Vigabatrin API Revenue Market Share by Country in 2021
Figure 37. United States Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Vigabatrin API Sales Market Share by Region in 2021
Figure 42. APAC Vigabatrin API Revenue Market Share by Regions in 2021
Figure 43. China Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Vigabatrin API Sales Market Share by Country in 2021
Figure 50. Europe Vigabatrin API Revenue Market Share by Country in 2021
Figure 51. Germany Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Vigabatrin API Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Vigabatrin API Revenue Market Share by Country in 2021
Figure 58. Egypt Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Vigabatrin API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Vigabatrin API in 2021
Figure 64. Manufacturing Process Analysis of Vigabatrin API
Figure 65. Industry Chain Structure of Vigabatrin API
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)